UNION therapeutics A/S: Financial statements 2015
CVR: 33963750
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
UNION therapeutics A/S (CVR 33963750) has filed annual accounts for 2015. In 2015, the company reported revenue of USD 690,674 and a net result of USD -223,943 compared with DKK 578,227 the year before. The profit margin was -32.4%. Equity in the 2015 report amounted to USD -70,637.
- Revenue
- USD 690,674
- Gross Profit
- USD -154,481
- Profit/Loss
- USD -223,943
- Equity
- USD -70,637
- Total Assets
- USD 245,501
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 691K USD | -154K USD | -224K USD | -71K USD | - |
| 2014 | - | 3.1M | 578K | 988K | - |
| 2013 | - | 1.2M | 359K | 410K | - |
Official annual report
How creditworthy is UNION therapeutics A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
UNION therapeutics A/S has published its annual report for 2014. Gross profit came to DKK 3,055,657, and the net result was DKK 578,227.
About UNION therapeutics A/S
UNION therapeutics A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AntibioTx A/S and ANTIBIOTX ApS. The management consists of Kim Domela Kjøller, Morten Otto Alexander Sommer and Rasmus Vendler Toft-Kehler. The board consists of Stig Løkke Pedersen (chair), Andrew John Oakley, Morten Otto Alexander Sommer and Peter Kristensen. The company's owners include MANJIN ApS, VENDLER ApS and T&W HOLDING A/S. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -11,802,644 and a net result of DKK -32,142,051 compared with DKK -98,922,000 the year before. Equity in the 2025 report amounted to DKK -147,650,138.